The preliminary study of pcDNA3. 1(+)-gbpB-chitosan nanoparticles as a novel nasal delivery system for anti-carious vaccine

Medical Journal of Wuhan University

Volumn 26, Issue 3, 2005, Pages 351-354

  Wei, Kewen ^a   Fan, Mingwen ^a   Wu, Buling ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Chitosan Nanoparticles; Gene Vaccine; Glucan binding Protein; Streptococcus Mutans

Indexed keywords

ANTICARIES AGENT; CHITOSAN; GLUCAN BINDING PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NANOPARTICLE; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENTAL CARIES; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; NOSE MUCOSA; RAT; SALIVA ANALYSIS;

EID: 33747052266     PISSN: 16718852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mattos-Graner RO, Jin S, King WF, et al. Cloning of the Streptococcus mutans gene encoding glucan binding protein B and analysis of genetic diversity and protein production in clinical isolates. Infect Immun, 2001,69:6 931
2. Wei KW, Wu BL, Xiao MZ, et al. Establishment of gene vaccine for caries prevention in the cells of mammal and its expression characteristics. Chinese Journal of Clinical Rehabilitation, 2004,8(14):2 750
3. Smith DJ. Dental caries vaccines: prospects and concerns. Crit Rev Oral Biol Med, 2002,13(4):335
4. Haast W, Banas JA. Ligand-binding properties of the carboxyl-terminal repeat domain of streptococcus mutans glucan-binding protein A. J Bacteriology, 2000,182(3): 728
5. Borchard G. Chitosans for gene delivery. Adv Drug Deliv, 2001,5:145
6. Iqbalet M. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine, 2003,21(13-14):1 478
7. Roy K, Mao HQ, Huang SK, et al. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine peanut allergy model. Natmed, 1999,5:387
8. Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharm Res, 1998,15:1 326
9. Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol, 2003,55(11):1 451
10. Mao HQ, Roy K, Tvoung-Le VL, et al. Chitosan- DNA nanoparticles as gene carriers: synthesism, characterisation and transfection efficiency. J Control Rel, 2001,70: 399
11. Leong KW. DNA-polycation nanospheres as non - viral gene delivery vehicles. J Controlled Release, 1998,53:183